Transgene Biotek incorporates wholly owned subsidiary company

24 Dec 2020 Evaluate

Transgene Biotek has incorporated a wholly owned subsidiary company namely 'Peroral Bio' on December 23, 2020. The company has incorporated a wholly owned subsidiary company for carrying out the business of Pharmaceutical and biotechnology related operations and formulations.

Transgene Biotek (TBL) is engaged in manufacturing drugs for:New Drug Delivery System (NDDS)-Oral Delivery of Insulin,Oral Delivery Hepatitis B Vaccine and Pegylation of Protein Drugs.

Transgene Biotek Share Price

2.84 0.21 (7.98%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 399.15
Indegene 459.35
CMS Info Systems 300.35
JITF Infralogistics 355.50
Sagility 39.22
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×